Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

Impact of Early Life Adversity on Epigenome at Molecular Level Mapped in Macaques

June 18, 2026
Continue Reading
impact-of-early-life-adversity-on-epigenome-at-molecular-level-mapped-in-macaques
Posted inGenetics

Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine

June 18, 2026
Continue Reading
historic-biotech-ipo,-merck,-protillion’s-ai-deal,-testing-a-lassa–rabies-vaccine
Posted inGenetics

IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings

June 18, 2026
Continue Reading
idbs-and-alchemi-agree-to-accelerate-ai-driven-biopharma-regulatory-filings
Posted inBiotechnology

Moderna’s flu candidate sails through FDA advisory committee in unanimous votes

June 18, 2026
Continue Reading
moderna’s-flu-candidate-sails-through-fda-advisory-committee-in-unanimous-votes
Posted inGenetics

China Sets Framework for Advanced Therapeutic Development

June 18, 2026
Continue Reading
china-sets-framework-for-advanced-therapeutic-development
Posted inGenetics

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain

June 18, 2026
Continue Reading
perseverance,-persistence-key-to-car-t-success,-say-ross-prize-winners-carl-june-and-michel-sadelain
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

mrna-flu-vaccine-provides-broad-immune-defense-against-diverse-influenza-strains
Posted inBiotechnology

mRNA Flu Vaccine Provides Broad Immune Defense Against Diverse Influenza Strains

June 15, 2026
A groundbreaking new study conducted by researchers at Washington University School of Medicine in St. Louis illuminates the promising potential…
Read More
adaptive-brain-stimulation-tailored-to-every-step-of-parkinson’s-patients
Posted inBiotechnology

Adaptive Brain Stimulation Tailored to Every Step of Parkinson’s Patients

June 15, 2026
Researchers at the University of California, San Francisco (UCSF) have pioneered a groundbreaking approach to deep brain stimulation (DBS) that…
Read More
traws-defers-midphase-flu-study-after-negative-regulatory-review
Posted inBiotechnology

Traws defers midphase flu study after negative regulatory review

June 15, 2026
U.K. regulators have issued a “negative review” of Traws Pharma’s planned human influenza challenge study, forcing the biotech to defer a…
Read More
neumora-to-lay-off-35%-of-staff-after-navacaprant-goes-0-for-3-in-late-stage-depression-studies
Posted inBiotechnology

Neumora to lay off 35% of staff after navacaprant goes 0 for 3 in late-stage depression studies

June 15, 2026
Roughly eighteen months after Neumora Therapeutics reported the first late-stage flop for navacaprant in major depressive disorder (MDD), the asset…
Read More
3d-printing-biocemented-porous-structures-with-precision
Posted inBiotechnology

3D Printing Biocemented Porous Structures with Precision

June 15, 2026
In a groundbreaking advancement poised to transform the landscape of additive manufacturing, a team of researchers has unveiled an innovative…
Read More
soligenix-axes-lymphoma-program-after-phase-3-setback,-mulls-m&a-options
Posted inBiotechnology

Soligenix axes lymphoma program after phase 3 setback, mulls M&A options

June 15, 2026
Soligenix has scrapped its cutaneous T-cell lymphoma (CTCL) program in the wake of a phase 3 setback, leaving the biotech focused…
Read More
activating-light-switch-protein-enhances-cancer’s-vulnerability-to-treatment
Posted inBiotechnology

Activating Light Switch Protein Enhances Cancer’s Vulnerability to Treatment

June 15, 2026
Cancer cells have long been notorious for their ability to evade therapeutic attacks, often slipping into a dormant state where…
Read More
sympathetic-signaling-eases-ards-via-hdc/slc7a11-axis
Posted inBiotechnology

Sympathetic Signaling Eases ARDS via HDC/SLC7A11 Axis

June 15, 2026
In a groundbreaking study poised to reshape the understanding and treatment of acute respiratory distress syndrome (ARDS), researchers have unraveled…
Read More
glyphosate-exposure-linked-to-pregnancy-hormone-disruption
Posted inBiotechnology

Glyphosate Exposure Linked to Pregnancy Hormone Disruption

June 15, 2026
In a groundbreaking study published this June in the Journal of Exposure Science and Environmental Epidemiology, researchers have unveiled compelling…
Read More
beating-the-heat:-how-vertical-greenery-cools-urban-spaces
Posted inBiotechnology

Beating the Heat: How Vertical Greenery Cools Urban Spaces

June 15, 2026
In the increasingly urbanized world, the phenomenon known as the Urban Heat Island (UHI) effect has become a pressing environmental…
Read More

Posts pagination

Previous page 1 … 17 18 19 20 21 … 1,989 Next page
You May Have Missed
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

fda-clears-dexcom’s-stelo-otc-glucose-monitor-for-use-with-children
Posted inMedical Technology

FDA clears Dexcom’s Stelo OTC glucose monitor for use with children

irhythm-hit-by-cyberattack-that-compromised-patient-data,-says-operations-unaffected
Posted inMedical Technology

iRhythm hit by cyberattack that compromised patient data, says operations unaffected

amid-us-investment-tour,-j&j-makes-$1b-stop-in-florida-to-upgrade-contact-lens-plant
Posted inMedical Technology

Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant

Privacy Policy    Terms

Scroll to Top